NO964102L - Pharmaceuticals and drugs for the prevention and treatment of endothelial dysfunctions - Google Patents
Pharmaceuticals and drugs for the prevention and treatment of endothelial dysfunctionsInfo
- Publication number
- NO964102L NO964102L NO964102A NO964102A NO964102L NO 964102 L NO964102 L NO 964102L NO 964102 A NO964102 A NO 964102A NO 964102 A NO964102 A NO 964102A NO 964102 L NO964102 L NO 964102L
- Authority
- NO
- Norway
- Prior art keywords
- prevention
- treatment
- pharmaceuticals
- drugs
- endothelial dysfunctions
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4406—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 3, e.g. zimeldine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/55—Protease inhibitors
- A61K38/556—Angiotensin converting enzyme inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Emergency Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Det er beskrevet anvendelse av nitrogenmonoksydfrlgivende eller ¿overførende forbindelser, av stlmulatorer av den endogene nitrogenmonoksyddannelsen samt av stimulatorer av guanylatzyklase for forebyggelse, behandling og helbredelse av endothellske dysfunksjoner og av med disse dysfunksjonene Innledede eller ved disse fremkalte sykdonroer, samt anvendelsen av nevnte forbindelser for fremstilling av farmasøytiske produkter for de nevnte anvendelsesområdene.There is disclosed the use of nitrogen monoxide releasing or transmitting compounds, of stimulators of the endogenous nitrogen monoxide formation and of guanylate cyclase stimulators for the prevention, treatment and cure of endothelial dysfunctions and of these dysfunctions. of pharmaceutical products for the aforementioned applications.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4410997A DE4410997A1 (en) | 1994-03-30 | 1994-03-30 | Pharmaceutical preparations and drugs for the prevention and treatment of endothelial dysfunctions |
PCT/DE1995/000421 WO1995026725A1 (en) | 1994-03-30 | 1995-03-28 | Pharmaceutical preparations and medicaments for the prevention and treatment of endothelial dysfunction |
Publications (2)
Publication Number | Publication Date |
---|---|
NO964102D0 NO964102D0 (en) | 1996-09-27 |
NO964102L true NO964102L (en) | 1996-09-27 |
Family
ID=6514213
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO964102A NO964102L (en) | 1994-03-30 | 1996-09-27 | Pharmaceuticals and drugs for the prevention and treatment of endothelial dysfunctions |
Country Status (19)
Country | Link |
---|---|
EP (1) | EP0752858A1 (en) |
JP (1) | JPH09510979A (en) |
CN (1) | CN1150387A (en) |
BG (1) | BG63073B1 (en) |
CA (1) | CA2186783A1 (en) |
CZ (1) | CZ283696A3 (en) |
DE (2) | DE4410997A1 (en) |
EE (1) | EE9600139A (en) |
FI (1) | FI963883A (en) |
HU (1) | HU220165B (en) |
IS (1) | IS4365A (en) |
LT (1) | LT4310B (en) |
LV (1) | LV11666B (en) |
MX (1) | MX9604434A (en) |
NO (1) | NO964102L (en) |
PL (1) | PL316528A1 (en) |
SI (1) | SI9520047A (en) |
SK (1) | SK121896A3 (en) |
WO (1) | WO1995026725A1 (en) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9423868D0 (en) * | 1994-11-25 | 1995-01-11 | Wellcome Found | Compounds for use in medicine |
DE19604361C2 (en) * | 1996-02-07 | 1999-01-14 | Sanol Arznei Schwarz Gmbh | Use of gas-tight primary packaging for pharmaceutical compositions |
DE19654895C2 (en) * | 1996-02-07 | 2000-07-27 | Sanol Arznei Schwarz Gmbh | Detection method |
DE19726812A1 (en) * | 1997-06-25 | 1999-01-07 | Isis Pharma Gmbh | New nitryl-oxy-methyl derivatives derived from pentaerythritol |
US5958926A (en) * | 1996-11-01 | 1999-09-28 | Nitromed, Inc. | Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses |
US6331543B1 (en) | 1996-11-01 | 2001-12-18 | Nitromed, Inc. | Nitrosated and nitrosylated phosphodiesterase inhibitors, compositions and methods of use |
USRE37234E1 (en) | 1996-11-01 | 2001-06-19 | Nitromed, Inc. | Nitrosated and nitrosylated phosphodiestrase inhibitor compounds, compositions and their uses |
ZA989356B (en) * | 1997-10-16 | 1998-11-16 | Isis Pharma Gmbh | Pharmaceutical preparations |
DE19745622A1 (en) * | 1997-10-16 | 1999-04-22 | Isis Pharma Gmbh | New nitric acid ester derivatives of pentaerythritol |
DE69830069T3 (en) * | 1997-10-17 | 2012-02-09 | Ark Therapeutics Ltd. | USE OF INHIBITORS OF THE RENIN-ANGIOTENSIN SYSTEM FOR THE TREATMENT OF HYPOXIA OR REDUCED METABOLIC CHANGE |
US6472425B1 (en) | 1997-10-31 | 2002-10-29 | Nitromed, Inc. | Methods for treating female sexual dysfunctions |
AU5503199A (en) * | 1998-06-24 | 2000-01-10 | Alpharma-Isis Gmbh And Co. Kg | Analytic substrates and antioxidative agents |
US6465463B1 (en) | 1999-09-08 | 2002-10-15 | Nitromed, Inc. | Methods of treating and preventing congestive heart failure with hydralazine compounds and isosorbide dinitrate or isosorbide mononitrate |
US6635273B1 (en) | 1999-10-29 | 2003-10-21 | Trustees Of Boston University | Methods of treating vascular diseases characterized by nitric oxide insufficiency |
US7537785B2 (en) | 1999-10-29 | 2009-05-26 | Nitromed, Inc. | Composition for treating vascular diseases characterized by nitric oxide insufficiency |
US7708989B2 (en) | 1999-10-29 | 2010-05-04 | Nitromed, Inc. | Methods of treating vascular diseases characterized by nitric oxide insufficiency |
US7235237B2 (en) | 1999-10-29 | 2007-06-26 | Nitromed, Inc. | Methods of treating vascular diseases characterized by nitric oxide insufficiency |
ES2258365B1 (en) * | 2003-10-03 | 2007-12-01 | Lacer, S.A. | DERIVATIVES OF DISULFIDE, SULFIDE, SULFOXIDE AND SULFONE OF CYCLING SUGARS AND THEIR USES. |
WO2008124505A2 (en) * | 2007-04-05 | 2008-10-16 | Ironwood Pharmaceuticals,Inc. | Soluble guanylate cyclase (sgc) modulators for treatment of lipid related disorders |
MX2012013774A (en) * | 2010-05-27 | 2012-12-17 | Merck Sharp & Dohme | Soluble guanylate cyclase activators. |
RU2467748C1 (en) * | 2011-08-08 | 2012-11-27 | Федеральное государственное автономное образовательное учреждение высшего профессионального образования "Белгородский государственный национальный исследовательский университет" | 3-(2,2,2-trimethylhydrazinium) propionate derivative - 3-(2,2,2-trimethylhydrazinium) potassium propionate glycinate exhibiting endothelioprotective activity |
JP5360939B2 (en) * | 2011-09-28 | 2013-12-04 | 国立大学法人徳島大学 | A therapeutic agent for arteriosclerosis comprising a nitrosonifedipine derivative as an active ingredient |
Family Cites Families (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR984523A (en) * | 1949-02-10 | 1951-07-06 | Trinitro-triethanolamine phosphate and method of preparation | |
DE1695897C3 (en) * | 1966-07-04 | 1979-02-15 | Takeda Chemical Industries Ltd | N-acyl-sydnonimines, their salts, processes for their preparation and medicaments containing these compounds |
US3886186A (en) * | 1971-04-29 | 1975-05-27 | American Home Prod | Mononitrate esters of 1,4:3,6-dianhydro-d-glucitol |
GB1356374A (en) * | 1971-04-29 | 1974-06-12 | American Home Prod | Mononitrate esters of 1,3 3,6-dianhydro-d-glucitol |
DE2532124C3 (en) * | 1975-07-18 | 1979-04-19 | Cassella Ag, 6000 Frankfurt | Process for the production of 4-amino-morpholine |
US4200640A (en) * | 1976-04-02 | 1980-04-29 | Chugai Seiyaku Kabushiki Kaisha | Nitric ester of N-(2-hydroxyethyl)nicotinamide and pharmaceutical use |
DE2623800C3 (en) * | 1976-05-28 | 1978-11-23 | Sanol Schwarz-Monheim Gmbh, 4000 Duesseldorf | Super-saturated aqueous isosorbide dinitrate solution, manufacturing process and use |
US4065488A (en) * | 1977-02-24 | 1977-12-27 | American Home Products Corporation | Process for preparing 1,4:3,6-dianhydro-D-glucitol 2-nitrate |
DE2903927C2 (en) * | 1979-02-02 | 1981-03-12 | Sanol Schwarz-Monheim Gmbh, 4019 Monheim | Process for the selective production of isosorbide-5-nitrate |
DE3028873C2 (en) * | 1980-07-30 | 1983-10-27 | Boehringer Mannheim Gmbh, 6800 Mannheim | Process for the preparation of 1,4 to 3,6-dianhydro-D-glucitol-5-nitrate (isosorbide-5-nitrate) |
DE3102947A1 (en) * | 1981-01-29 | 1982-09-02 | Heinrich Mack Nachf., 7918 Illertissen | METHOD FOR PRODUCING ISOSORBIDE 5-NITRATE |
FR2500835A1 (en) * | 1981-02-27 | 1982-09-03 | Poudres & Explosifs Ste Nale | PROCESS FOR THE SYNTHESIS OF MONONITRATES OF ISOSORBIDE |
DE3117612A1 (en) * | 1981-05-05 | 1982-11-25 | Cassella Ag, 6000 Frankfurt | METHOD FOR PRODUCING ISOSORBIDE 5-NITRATE |
DE3124410A1 (en) * | 1981-06-22 | 1983-01-05 | Heinrich Mack Nachf., 7918 Illertissen | METHOD FOR PRODUCING ISOSORBIDE-2-NITRATE |
JPS5910513A (en) * | 1982-07-12 | 1984-01-20 | Nitto Electric Ind Co Ltd | Pharmaceutical preparation of drug |
DE3325652A1 (en) * | 1983-07-15 | 1985-01-24 | Dr. Rentschler Arzneimittel Gmbh & Co, 7958 Laupheim | Solid, stable pharmaceutical formulations containing isosorbide 5-mononitrate, and process for the production thereof |
DE3328094A1 (en) * | 1983-08-04 | 1985-02-21 | H. Trommsdorff GmbH & Co, 5110 Alsdorf | Desensitised pharmaceutical formulation of explosive nitric acid esters |
EP0143507B1 (en) * | 1983-11-25 | 1989-09-20 | TOSHIN CHEMICAL CO., Ltd. | A method for the preparation of isosorbide-5-nitrate and sodium isosorbide-5-nitrate hydrate as a precursor thereof |
DD244980A1 (en) * | 1985-12-18 | 1987-04-22 | Isis Chemie Zwickau Veb | PROCESS FOR PREPARING N-MORPHOLINOAMINOACETONITRILE AND ITS HYDROCHLORIDE |
DD293492A5 (en) * | 1987-11-26 | 1991-09-05 | Isis-Chemie Gmbh,De | METHOD FOR THE PRODUCTION OF A GLYCEROLTRINITRATE DRUG FILM WITH SIMILARLY DELAYED DRUG RELEASE |
US5284872A (en) * | 1989-09-12 | 1994-02-08 | Schwarz Pharma Ag | Nitrato alkanoic acid derivatives, methods for their production, pharmaceutical compositions containing the derivatives and medicinal uses thereof |
DE4007705C1 (en) * | 1990-03-10 | 1991-09-26 | G. Pohl-Boskamp Gmbh & Co. Chemisch-Pharmazeutische Fabrik, 2214 Hohenlockstedt, De | |
DE4038203A1 (en) * | 1990-11-30 | 1992-06-04 | Kali Chemie Pharma Gmbh | Pharmaceutical spray-prepn. for admin. of nitrate(s) - esp. for treatment of cardiovascular, disorders, asthma, migraine and colic |
US5385937A (en) * | 1991-04-10 | 1995-01-31 | Brigham & Women's Hospital | Nitrosation of homocysteine as a method for treating homocysteinemia |
-
1994
- 1994-03-30 DE DE4410997A patent/DE4410997A1/en not_active Withdrawn
-
1995
- 1995-03-28 JP JP7525343A patent/JPH09510979A/en active Pending
- 1995-03-28 SI SI9520047A patent/SI9520047A/en unknown
- 1995-03-28 DE DE19580261T patent/DE19580261D2/en not_active Expired - Lifetime
- 1995-03-28 HU HU9602671A patent/HU220165B/en not_active IP Right Cessation
- 1995-03-28 CZ CZ962836A patent/CZ283696A3/en unknown
- 1995-03-28 CA CA002186783A patent/CA2186783A1/en not_active Abandoned
- 1995-03-28 EP EP95914275A patent/EP0752858A1/en not_active Withdrawn
- 1995-03-28 SK SK1218-96A patent/SK121896A3/en unknown
- 1995-03-28 MX MX9604434A patent/MX9604434A/en not_active IP Right Cessation
- 1995-03-28 EE EE9600139A patent/EE9600139A/en unknown
- 1995-03-28 WO PCT/DE1995/000421 patent/WO1995026725A1/en not_active Application Discontinuation
- 1995-03-28 CN CN95193401A patent/CN1150387A/en active Pending
- 1995-03-28 PL PL95316528A patent/PL316528A1/en unknown
-
1996
- 1996-09-19 LV LVP-96-378A patent/LV11666B/en unknown
- 1996-09-25 IS IS4365A patent/IS4365A/en unknown
- 1996-09-27 NO NO964102A patent/NO964102L/en not_active Application Discontinuation
- 1996-09-27 FI FI963883A patent/FI963883A/en unknown
- 1996-10-22 LT LT96-148A patent/LT4310B/en not_active IP Right Cessation
- 1996-10-22 BG BG100930A patent/BG63073B1/en unknown
Also Published As
Publication number | Publication date |
---|---|
EE9600139A (en) | 1997-04-15 |
NO964102D0 (en) | 1996-09-27 |
LT4310B (en) | 1998-03-25 |
LV11666B (en) | 1997-06-20 |
FI963883A0 (en) | 1996-09-27 |
LV11666A (en) | 1997-02-20 |
CZ283696A3 (en) | 1998-03-18 |
DE4410997A1 (en) | 1995-10-26 |
HU220165B (en) | 2001-11-28 |
SK121896A3 (en) | 1998-10-07 |
IS4365A (en) | 1996-09-25 |
BG100930A (en) | 1997-07-31 |
AU2134595A (en) | 1995-10-23 |
PL316528A1 (en) | 1997-01-20 |
CA2186783A1 (en) | 1995-10-12 |
BG63073B1 (en) | 2001-03-30 |
DE19580261D2 (en) | 1997-05-28 |
LT96148A (en) | 1997-12-29 |
MX9604434A (en) | 1997-12-31 |
FI963883A (en) | 1996-09-27 |
WO1995026725A1 (en) | 1995-10-12 |
AU698359B2 (en) | 1998-10-29 |
CN1150387A (en) | 1997-05-21 |
EP0752858A1 (en) | 1997-01-15 |
HUT76676A (en) | 1997-10-28 |
JPH09510979A (en) | 1997-11-04 |
SI9520047A (en) | 1997-06-30 |
HU9602671D0 (en) | 1996-11-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO964102L (en) | Pharmaceuticals and drugs for the prevention and treatment of endothelial dysfunctions | |
CY2123B1 (en) | Isoxazole-4-carboxamides and hydroxyalkylidene-cyanoacetamides drugs containing these compounds and use of such drugs | |
NO892083L (en) | PROCEDURE FOR THE PREPARATION OF ARYLMETHYLNYL DERIVATIVES OF TIAZOLIDINONES, IMIDAZOLIDINONES AND OKSAZOLIDINONES. | |
NO303638B1 (en) | Condensed indole derivatives, pharmaceutical preparations containing them and the use of the derivatives | |
NO307787B1 (en) | Xanthine compounds with terminally aminated alkinol side chains, drugs containing the compounds and uses of the compounds for the preparation of drugs | |
NO308738B1 (en) | Bicyclically condensed pyridines, drugs containing them and use of the compounds for the preparation of drugs | |
NO901430D0 (en) | PROCEDURE FOR THE PREPARATION OF 4 (3H) -PTERIDIONS, AND MEDICINES CONTAINING SUCH. | |
IE940341L (en) | Anti-atherosclerotic diaryl compound | |
DE69009045D1 (en) | Capsule for medical purposes and device for activating it. | |
NO880179D0 (en) | POLYMER COMPLEXES, PROCEDURE FOR THE PREPARATION OF THESE, AND PHARMACEUTICAL AGENTS CONTAINING THESE. | |
NO890062L (en) | 3,5-DIHYDROCARBOXYLIC ACIDS AND DERIVATIVES THEREOF, AND PROCEDURES FOR THE PREPARATION OF THESE. | |
NO903527D0 (en) | LABORATORY DEVICE, AND PROCEDURE FOR TREATMENT OF EXAMPLES. | |
NO902809L (en) | DEVICE AND PROCEDURE FOR THE MANUFACTURE OF SYNTHESIC GAS, AND USE OF THIS. | |
NO893826D0 (en) | PROCEDURE FOR THE PREPARATION OF 2'-HALOMETHYLIDE, 2'-ETHENYLIDE AND 2'-ETHENYLADENOSIN DERIVATIVES. | |
DK170788A (en) | DIHYDROPYRIDAZINE DERIVATIVES, PROCEDURES FOR PREPARING IT, AND MEDICINES CONTAINING THESE | |
EP0515995A3 (en) | N-(5-thioxo-l-prolyl)-l-cysteine, derivatives thereof, processes for the preparation thereof and pharmaceutical compositions containing them | |
NO903386D0 (en) | PROCEDURE FOR THE PREPARATION OF 4- (N-SUBSTITUTED AMINO) -2-BUTYNYL-1-CARBAMATES AND THIO-CARBAMATES AND DERIVATIVES THEREOF. | |
DK578589A (en) | PHARMACEUTICAL PREPARATION CONTAINING LABDANTERPENOID DERIVATIVES AND PYRIMIDO (6.1-A) ISOQUINOLIN-4 UNDERGRATES, ITS PREPARATION AND USE | |
TR199600117A2 (en) | Procedure for substituting benzolsulfonylurea and thiourea, the use of these substances and the use of pharmacy-related substances on the basis of these compositions and the healing agents containing these compounds. | |
DK131188D0 (en) | 3- (2-HALOGENALKYL) -1,4-OXATHIINES AND 2 (2-HALOGENALKYL) -1,4-DITHIINES, AND PHARMACEUTICAL PREPARATIONS CONTAINING THESE FOR THE TREATMENT OF LEUKAEMI AND TUMORS | |
NO871375D0 (en) | BIS-TERTIAER BUTYLAMINO-SUBSTITUTED 1,3,5-TRIAZINE DERIVATIVES, PROCEDURES FOR THEIR PREPARATION, PHARMACEUTICALS CONTAINING THESE COMPOUNDS AND THEIR USE. | |
DE3878087D1 (en) | 2-HYDROXYBENZOPHENONE HYDRAZIDES AND DERIVATIVES THEREOF. | |
GR3015107T3 (en) | Use of zofenopril for the preparation of drugs against rheumatoid arthritis. | |
BR9008053A (en) | Iomer of low molecular weight copolymer amides, composition including the same, and reaction product thereof. | |
NO960664L (en) | Substituted benzenesulfonylureas and thioureas, processes for their preparation, their use for the preparation of pharmaceutical preparations and medicaments containing them |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |